Vaccination

Covaxin approval requested in US for ages 2-18

US company Ocugen announced Friday that it had asked authorities for emergency use authorization for COVID-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.

Pediatrics

What parents need to know about the COVID-19 vaccine for kids

On October 29, the U.S. Food and Drug Administration (FDA) gave emergency authorization for a child-size dose of Pfizer's COVID-19 vaccine for use in kids ages five to 11. Some 28 million children could be eligible by early ...

page 22 from 40